Scorpius Holdings, Inc.

SCPX

OTC

Healthcare

Biotechnology

Morrisville, NC, US90 employeesscorpiusbiologics.com

—

At a Glance

AI-generated

Revenue breakdown: Grant (100%).

8-K

Scorpius Holdings, Inc. issued three non-convertible secured promissory notes to 3i, L.P. on February 12 ($30,426.95), February 26 ($190,907.77), and March 11, 2026 ($27,109.10), each accruing 5.0% interest per annum, maturing in August/September 2026 or earlier upon corporate event or default, with a 15% premium on payments. The notes include customary events of default and holder redemption rights upon subsequent financings.

—

Market Cap

—

Revenue

—

Net Income

Employees90

Fundamentals

How The Business Makes Money

Revenue by Segment

Grant100%($30M)

Activity

What Changed Recently

Acquisition/Disposition

Jan 28, 2026

above of this Current Report on Form 8-K is incorporated by reference in this Item 2.04. Item 9.01. Financial Statements and Exhibits. (b) Pro forma financial i

Material Agreement+3 More

Mar 18, 2026

. Entry Into a Material Definitive Agreement. On February 12, 2026, Scorpius Holdings, Inc. (the “Company”) issued a non-convertible promissory note (the “First

Exhibits Only

Mar 9, 2026

above of this Current Report on Form 8-K is incorporated by reference in this Item 2.04. Item 9.01. Financial Statements and Exhibits. (b) Pro forma financial i

Material Agreement+3 More

Jan 12, 2026

. Entry Into a Material Definitive Agreement. On December 16, 2025, Scorpius Holdings, Inc. (the “Company”) issued a non-convertible promissory note (the “First

Peer Companies

Company	Price	Change	Market Cap	P/E
GBLXGB Sciences, Inc.	—	—	—	—
NEPTFNeptune Wellness Solution...	—	—	—	—
AMPEAmpio Pharmaceuticals, In...	—	—	—	—
VRSYFVMS Rehab Systems, Inc.	—	—	—	—
BNYNBanyan Corp.	—	—	—	—
EMYSFEasy Technologies Inc.	—	—	—	—
IRBSIRBS	—	—	—	—
RGMPRegnum Corp.	—	—	—	—

Analyst View

Company Profile

CIK0001476963

ISINUS42237K5083

Phone919 240 7133

Address627 Davis Drive, Morrisville, NC, 27560, US

SEC EDGAR